DYADIC INTERNATIONAL INC (DYAI) Current Ratio
- Current ratio · latest quarter: Value 1.65×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.65× | Current assets / current liabilities. $6.41M ÷ $3.88M ≈ 1.65× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 6.41M USD | Assets, Current |
| Current obligations | 3.88M USD | Liabilities, Current |
| Cash and equivalents | 1.43M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 1.30M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | |
| Payables | 816.06K USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.41M | $3.88M | $1.43M | (m) | $1.30M | (m) | $816.06K | (m) | 1.65× |
| 2026-03-31 | $7.70M | $3.18M | $4.25M | (m) | $996.46K | (m) | $1.06M | (m) | 2.42× |
| 2025-12-31 | $9.90M | $3.69M | $4.62M | (m) | $1.09M | (m) | $852.02K | (m) | 2.68× |
| 2025-09-30 | $11.55M | $4.05M | $5.83M | (m) | $916.57K | (m) | $1.21M | (m) | 2.85× |
| 2025-06-30 | $7.41M | $3.66M | $2.14M | (m) | $715.32K | (m) | $738.79K | (m) | 2.02× |
| 2025-03-31 | $7.81M | $1.96M | $5.06M | (m) | $221.72K | (m) | $448.39K | (m) | 3.98× |
| 2024-12-31 | $9.83M | $2.45M | $6.51M | (m) | $237.03K | (m) | $482.32K | (m) | 4.01× |
| 2024-09-30 | $10.69M | $2.08M | $5.92M | (m) | $352.93K | (m) | $561.80K | (m) | 5.15× |
| 2024-06-30 | $10.50M | $1.95M | $6.13M | (m) | $249.81K | (m) | $432.52K | (m) | 5.39× |
| 2024-03-31 | $12.54M | $2.26M | $10.57M | (m) | $246.14K | (m) | $661.24K | (m) | 5.54× |
| 2023-12-31 | $8.07M | $2.25M | $6.52M | (m) | $466.16K | (m) | $656.45K | (m) | 3.58× |
| 2023-09-30 | $9.09M | $1.46M | $7.40M | (m) | $417.88K | (m) | $600.15K | (m) | 6.24× |
| 2023-06-30 | $11.07M | $2.00M | $5.84M | (m) | $767.60K | (m) | $905.88K | (m) | 5.53× |
| 2023-03-31 | $12.81M | $1.88M | $6.37M | (m) | $754.10K | (m) | $770.37K | (m) | 6.83× |
| 2022-12-31 | $13.42M | $2.45M | $5.79M | (m) | $330.00K | (m) | $1.28M | (m) | 5.48× |
| 2022-09-30 | $14.93M | $2.39M | $6.74M | (m) | $235.37K | (m) | $777.24K | (m) | 6.25× |
| 2022-06-30 | $16.93M | $3.40M | $9.48M | (m) | $1.15M | (m) | $1.10M | (m) | 4.98× |
| 2022-03-31 | $16.24B | $1.83B | $12.42B | (m) | $528.15M | (m) | $866.32M | (m) | 8.89× |
| 2021-12-31 | $21.01M | $2.56M | $15.75M | (m) | $277.83K | (m) | $1.55M | (m) | 8.22× |
| 2021-09-30 | $23.57M | $1.96M | $13.66M | (m) | $179.63K | (m) | $957.80K | (m) | 12.01× |
| 2021-06-30 | $26.16M | $3.29M | $14.02M | (m) | $291.44K | (m) | $2.43M | (m) | 7.95× |
| 2021-03-31 | $27.99M | $2.59M | $13.06M | (m) | $384.96K | (m) | $1.47M | (m) | 10.79× |
| 2020-12-31 | $29.78M | $1.63M | $20.64M | (m) | $294.20K | (m) | $1.01M | (m) | 18.32× |
| 2020-09-30 | $31.74M | $1.75M | $21.86M | (m) | $806.85K | (m) | $976.76K | (m) | 18.12× |
| 2020-06-30 | $33.73M | $1.64M | $11.78M | (m) | $564.67K | (m) | $1.14M | (m) | 20.58× |
| 2020-03-31 | $32.82M | $1.14M | $4.70M | (m) | $518.60K | (m) | $653.37K | (m) | 28.89× |
| 2019-12-31 | $35.64M | $1.59M | $4.82M | (m) | $558.53K | (m) | $943.38K | (m) | 22.44× |
| 2019-09-30 | $36.46M | $1.28M | $4.66M | (m) | $418.94K | (m) | $713.39K | (m) | 28.55× |
| 2019-06-30 | $38.00M | $1.45M | $4.78M | (m) | $504.51K | (m) | $963.26K | (m) | 26.21× |
| 2019-03-31 | $41.31M | $1.27M | $3.98M | (m) | $425.95K | (m) | $948.06K | (m) | 32.42× |
| 2018-12-31 | $42.75M | $849.64K | $2.39M | (m) | $318.74K | (m) | $309.06K | (m) | 50.31× |
| 2017-12-31 | $49.62M | $768.89K | $5.79M | (m) | $271.03K | (m) | $520.26K | (m) | 64.53× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |